0001493152-24-016062.txt : 20240426
0001493152-24-016062.hdr.sgml : 20240426
20240426083035
ACCESSION NUMBER: 0001493152-24-016062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240425
FILED AS OF DATE: 20240426
DATE AS OF CHANGE: 20240426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vazzano Joseph Walter
CENTRAL INDEX KEY: 0001715291
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 24878987
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR
CITY: CLEVELAND
STATE: OH
ZIP: 44103
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR
CITY: CLEVELAND
STATE: OH
ZIP: 44103
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2024-04-25
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001715291
Vazzano Joseph Walter
6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND
OH
44103
0
1
0
0
Chief Financial Officer
0
Common stock
2024-04-25
4
P
0
5608
3.14
A
233868
D
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.13 to $3.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
/s/ Joseph Vazzano
2024-04-26